Use of the mTOR inhibitor everolimus in a patient with multiple manifestations of tuberous sclerosis complex including epilepsy.
about
Efficacy and safety of Everolimus in children with TSC - associated epilepsy - Pilot data from an open single-center prospective study.Everolimus improves neuropsychiatric symptoms in a patient with tuberous sclerosis carrying a novel TSC2 mutationVariation in a range of mTOR-related genes associates with intracranial volume and intellectual disability.mTOR-Dependent Cell Proliferation in the Brain.
P2860
Use of the mTOR inhibitor everolimus in a patient with multiple manifestations of tuberous sclerosis complex including epilepsy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Use of the mTOR inhibitor ever ...... is complex including epilepsy.
@ast
Use of the mTOR inhibitor ever ...... is complex including epilepsy.
@en
type
label
Use of the mTOR inhibitor ever ...... is complex including epilepsy.
@ast
Use of the mTOR inhibitor ever ...... is complex including epilepsy.
@en
prefLabel
Use of the mTOR inhibitor ever ...... is complex including epilepsy.
@ast
Use of the mTOR inhibitor ever ...... is complex including epilepsy.
@en
P2860
P1476
Use of the mTOR inhibitor ever ...... is complex including epilepsy.
@en
P2093
James W Wheless
P2860
P356
10.1016/J.EBCR.2015.06.008
P577
2015-08-12T00:00:00Z